Skip to main content

News Release

The Tulalip Tribes

The Tulalip Tribes is pleased to announce the sponsorship of two medicinal Cannabis research projects at the Stanford University School of Medicine’s Behavioral and Functional Neuroscience Laboratory. This is a thirty-month, $2 million dollar research award, which commenced on May 1, 2018.

“Tulalip Tribes is committed to developing Cannabis-derived medicines with the potential to treat opioid addiction. We are proud to sponsor this cutting-edge research,” said Teri Gobin, Vice Chairman of the Tulalip Tribes. “Like so many communities across the nation, we are deploying an ever-increasing amount of resources to fight this epidemic. We decided a new approach was necessary. As sovereigns, we have a unique responsibility to our people, and providing a natural remedy to the opioid epidemic is our priority.” 

The two research projects are co-directed by Professor of Neurosurgery, Mehrdad Shamloon, and Professor of Bioengineering, Annelise Barron. The research is utilizing rodent models to study the efficacy and mechanism of action of cannabis flower extracts and purified tetrahydrocannabinol (THC)/cannabidiol (CBD) to treat heroin addiction and Alzheimer's disease.  

Scroll to Continue

Read More

These two respective studies are the first of their kind to look at the efficacy of using whole plant cannabis extracts to treat addiction and Alzheimer’s Disease. Currently, it is nearly impossible to obtain Federal funding to study the positive health benefits of cannabis, especially cannabis oil, so tribal support of this type of research is particularly important.  

About the Tulalip Tribes 

The Tulalip Tribes are the successors in interest to the Snohomish, Snoqualmie, Skykomish and other tribes and bands signatory to the 1855 Treaty of Point Elliott. Tribal government administers programs in health and human services, housing, and education. The Tribes have approximately 4,800 members. 

For more information visit